InvestorsHub Logo
Followers 11
Posts 1371
Boards Moderated 0
Alias Born 10/18/2018

Re: None

Wednesday, 03/03/2021 7:54:15 PM

Wednesday, March 03, 2021 7:54:15 PM

Post# of 43748
Seeking Alpha One Year Ago

CEL-SCI is extremely likely to witness clinical trial success with its only product, Multikine.

More than 350,000 patients die each year due to HSNCC
.
The drug has a total addressable market of over $2.0 billion in the U.S. alone.

Top line data are anticipated by the end of April.

CEL-SCI does not have to raise further cash to fund development efforts.


https://seekingalpha.com/article/4320856-cel-sci-food-for-thought-big-day
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News